Research Collaboration Unit

Keyphrases

1. Research Data Management 100%
2. Scholarly Document Processing 100%
3. ORCID 75%
4. Mendeley Data 62%
5. Data Platform 62%
6. Cultural Shift 50%
7. Resource Identification 50%
8. Sustainable Development Goal 2 50%
9. Research Resource Identifiers 50%
10. United Nations Sustainable Development Goals (UN SDGs) 50%
11. Policy Documents 50%
12. Platform Studies 50%
13. Data Ecosystem 50%
14. Data Needs 50%
15. Internet-enabled 50%
16. Open Research 50%
17. University System 50%
18. Large Community 50%
19. Early Career Research 50%
20. Community Outreach 50%
21. Three-form 50%
22. Unique Identifier 50%
23. Value Creation 50%
24. Knowledge Institutions 50%
25. Community Engagement 50%
26. Argument Mining 50%
27. University Leadership 50%
28. Referee 50%
29. Vice 50%
30. Student Staff 50%
31. Vice President 50%
32. 21st Century 50%
33. Open Knowledge 50%
34. Funding Agencies 50%
35. Community Perspectives 50%
36. Librarians 50%
37. Protein Family 50%
38. Co-authorship 50%
39. Functional Annotation 50%
40. Silent mutation 50%
41. Cancer Classification 50%
42. Cancer Prognosis 50%
43. Laparoscopic Surgery 50%
44. Clinical Benefit 50%
45. Clinical Costs 50%
46. Review Modeling 50%
47. Robotic Surgery 50%
48. C-erbB-2 50%
49. Epidermal Growth Factor Receptor 50%
50. Functional Conservation 50%
51. Glucose-lowering Drugs 50%
52. Risk Target 50%
53. Target Perturbation 50%
54. Tumor Immunogenicity 50%
55. Elderly People 50%
56. Minimally Invasive Treatment 50%
57. Clinical Effect 50%
58. CD86 50%
59. Acetylcholinesterase 50%
60. Long Non-coding RNA (LncRNA) 50%
61. Tumorigenesis 50%
62. Urinary Diversion 50%
63. Cystectomy 50%
64. Adult Cancer 50%
65. Nerve Trunk 50%
66. Systemic Inflammation Response Index 50%
67. Innervation 50%
68. Second Malignancy 50%
69. Ionizing Radiation 50%
70. Acid Response 50%
71. Hormone Resistance 50%
72. RAS Pathway 50%
73. Hormone-sensitive Prostate Cancer 50%
74. CD80 50%
75. Response Prediction 50%
76. CD4+ T Cell Activation 50%
77. Bladder Reconstruction 50%
78. Fixative 50%
79. Prognostic Value 50%
80. Cross-cultural Validation 50%
81. LINE-1 Retrotransposition 50%
82. Linguistic Validation 50%
83. Quality of Life Scale 50%
84. GWAS Summary Statistics 50%
85. Cyclin A 50%
86. Related Quality of Life 50%
87. Bladder Neck Reconstruction 50%
88. RhNGF 50%
89. Heterogeneous Expression 50%
90. Specific Quality of Life 50%
91. Fgf8 50%
92. Basic Fibroblast Growth Factor (bFGF) 50%
93. Initial Prostate Biopsy 50%
94. Gene Silencing 50%
95. Dosage Compensation 50%
96. Longitudinal Assessment 50%
97. Satiety Responsiveness 50%
98. Oral Iron Therapy 50%
99. Infant Behavior 50%
100. Developmental Deficits 50%